Skip to main content

TWO SIGMA INVESTMENTS, LP

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1179392 NEW YORK, NY

Position in HALO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$102,436,029
+$54,157,096 QoQ
Shares Held
1,584,961
+120.9% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 99.21133706129048.ToString("F0")% Shared 0.ToString("F0")% None 0.7886629387095329.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Derivatives in HALO

reported options exposure · as of Dec 31, 2020
CallValue
$747,425
CallShares
17,500
PutValue
$726,070
PutShares
17,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TWO SIGMA INVESTMENTS, LP holds $5,506,832,621 across 316 Biotechnology names. HALO ranks #10 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $102,436,029 1,584,961
2025-12-31 $48,278,933 717,369
2025-09-30 $96,509,866 1,315,924
2025-06-30 $22,880,372 439,838
2025-03-31 $41,223,046 646,028
2024-12-31 $11,810,504 247,030
2024-09-30 $2,811,170 49,112
2024-06-30 $2,564,906 48,986
2024-03-31 $4,629,058 113,792
2023-03-31 $8,188,852 214,424
2022-12-31 $31,356,110 551,074
2022-09-30 $4,236,276 107,139
2022-06-30 $25,098,964 570,431
2022-03-31 $5,557,756 139,362
2021-09-30 $4,434,648 109,013
2021-06-30 $16,488,371 363,100
2021-03-31 $17,358,882 416,380
2020-12-31 $726,070 17,000
2020-12-31 $747,425 17,500
2020-12-31 $10,633,551 248,971
2020-09-30 $11,160,406 424,673
2020-06-30 $20,757,776 774,255
2020-03-31 $19,874,236 1,104,738